English | 简体中文 | 繁體中文 | 한국어
Share:
Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court

Genoma has filed appeal to the decision of liquidation taken on May 4th 2017. Genoma considers this decision arbitrary due to the circumstances of the commercial and legal relationship with Premaitha.

Zutphen, The Netherlands, 19 May 2017

Genoma has concluded with Premaitha an agreement in March 15th 2015 for the supply of the genetic test Iona. The implementation of this contract implied significant investment specifically related to the use of the IONA Kits. Genoma represented 65% of Premaitha's business in 2015/16.

Genoma was forced to discontinue using the Premaitha Iona test some weeks after the serious legal claim against Premaitha's technology by Illumina (Patent Infringement). Premaitha has not been able to demonstrate that the Iona test doesn't infringe Illumina's patents.

Genoma blocked payments to Premaitha, a total of +€900k for several reasons:

  • A considerable amount has been claimed for failure in the supply;
  • Illumina sued Genoma for patent infringement because of the use of Premaitha's Iona;
  • Premaitha never offered valid support for defence despite they were selling a patent infringing product.

The British supplier sent several summons for payment and finally obtained a court decision ruling for the bankruptcy of Genoma officially on May 4th 2017. The official register was updated on the 9th of May 2017.

About ESPERITE
ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine established in 2000.

To learn more about ESPERITE Group, or to book an interview with CEO Frederic Amar: +31 575 548 998 - ir@esperite.com or visit the websites at
www.esperite.com and www.genoma.com.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Esperite N.V. via Globenewswire

Copyright © Thomson Reuters 2017. All rights reserved.
 Subscribe RSS Feed  
Press Releases
TGS Q3 2017 webcast and teleconference  
Oct 19, 2017 17:16 ET
GOGL - Equity offering: Issue of New Shares  
Oct 19, 2017 16:12 ET
Golar LNG Partners LP Third Quarter 2017 Cash Distribution  
Oct 19, 2017 14:30 ET
Active Biotech's partner Teva presents new data on laquinimod for the treatment of multiple sclerosis at 7th joint ECTRIMS-ACTRIMS Meeting  
Oct 19, 2017 14:00 ET
Elanders AB: Quarterly Report January - September 2017  
Oct 19, 2017 13:00 ET
INGREDION TO WEBCAST PRESENTATION FOR THE 2017 ANALYST DAY FIELD TRIP IN BRIDGEWATER, NEW JERSEY  
Oct 18, 2017 04:03 ET
Lubrizol to Present Webinar on Estane® TPU - High Performance Solutions for Surface Protection and Graphics  
Oct 18, 2017 01:03 ET
Astana International Financial Center (AIFC) and EXANTE agreed on the development and promotion of the crypto-assets market in The Republic of Kazakhstan.  
Oct 17, 2017 15:03 ET
INGREDION JOINS MORE THAN 270 CEOS TO ADVANCE DIVERSITY AND INCLUSION IN THE WORKPLACE  
Oct 12, 2017 22:03 ET
3E Company Evolves Brand Identity to Become Verisk 3E  
Oct 12, 2017 17:03 ET
More News >>
Copyright © 2017 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: